A Study to Investigate the Safety, Pharmacokinetics and Efficacy of APG-5918 in Healthy Subjects or Anemic Patients

PHASE1RecruitingINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

March 13, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

March 15, 2026

Conditions

Anemia

Interventions

DRUG

APG-5918

oral tablets 10mg, 50mg, 200mg.

DRUG

Placebo

Matching placebo

Trial Locations (2)

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

RECRUITING

Nanfang Hospital of Southern Medical University, Guangzhou